Seoul National University Bundang Hospital (SNUBH)
Bookimed erhebt keine zusätzlichen Gebühren für der Sehnervenatrophie-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Sehnervenatrophie einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Sehnervenatrophie-Behandlungsreise nie allein.
Optic nerve atrophy currently has no definitive cure. Vision loss from nerve damage is generally irreversible. South Korean tertiary hospitals focus on preserving remaining sight. Facilities like Asan Medical Center use advanced neuro-ophthalmology diagnostics to treat underlying causes like glaucoma or inflammation.
Bookimed Expert Insight: Patient volume signals high trust in South Korean ophthalmology. Seoul National University Hospital treats over 10,700 patients daily. While a total cure is unavailable, this massive scale supports deeper specialization in rare neuro-ophthalmic conditions. Rare disease care is even recognized at centers like RE:YOUTH.
Patient Consensus: Patients emphasize that preserving current vision is the most realistic goal. They recommend getting a second opinion from a neuro-ophthalmologist before starting any therapy.
South Korea provides advanced therapies for optic nerve disorders through regenerative medicine and bio-engineered implants. Key treatments include arterial stem cell infusion and bio-compatible artificial retinas. Specialized centers like SNUBH and Asan Medical Center utilize AI-driven diagnostics to manage complex optic nerve atrophy cases.
Bookimed Expert Insight: While many centers offer general stem cell therapy, Re:Youth is the only Korean facility providing specialized arterial stem cell infusion. This technique targets the blood-eye barrier more directly than standard injections. Focusing on such specialized delivery methods is essential for treating chronic atrophy where standard systemic medications typically fail.
Patient Consensus: Patients note that vision rehabilitation is the most practical help when structural recovery is unlikely. They emphasize asking for objective OCT scans rather than relying on vague claims of improvement.
Seoul National University Hospital, Asan Medical Center, and Gangnam Severance Hospital specialize in treating optic nerve atrophy for international patients. These JCI or KOIHA-accredited institutions provide advanced diagnostic methods like optical coherence tomography and multidisciplinary neuro-ophthalmology teams to stop vision loss progression.
Bookimed Expert Insight: While many seek a cure, Seoul's high-volume hospitals like Asan Medical Center focus on precision diagnostics to identify underlying causes. With 65,000+ annual operations, these centers excel at managing progression through neuro-ophthalmology rather than general eye care.
Patient Consensus: Patients note that large university hospitals are better for advanced testing than small clinics. They recommend sharing English medical records early to confirm if a neuro-ophthalmologist is available.